We herein report a 15-year-old girl who developed rapid progressive muscle weakness soon after the third injection of a bivalent human papilloma virus (HPV) vaccine. Although immunotherapies were performed for possible vaccine-related disorders, she died of respiratory failure 14 months after the onset of the disease. A genetic analysis identified a heterozygous p.P525L mutation of the fused in sarcoma (FUS) gene, and a histopathological analysis was also consistent with FUS-associated amyotrophic lateral sclerosis (ALS) without any evidence of neuroinflammation. We concluded the diagnosis to be FUS-ALS, although we cannot completely rule out the possibility that the vaccination worked as a trigger.
toll-like receptor 4 activation is involved in the pathogenesis of ALS. Thus, at this time, it is too premature to conclude whether or not the HPVV is completely safe in individuals with neurological conditions, and further investi- gations are needed.
https://t.co/EV45l1dAKj https://t.co/t0vm5Kshtg
国内症例報告
【Intern Med】
Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl
https://t.co/NRpDAWrM35